Studies have shown that there may be significant underreporting and overreporting of adverse events 70 , 71 .
← all excerpts
Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data.
1
—
—
Studies have shown that there may be significant underreporting and overreporting of adverse events 70 , 71 .